NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

抗老治療、服務市場:動向、成長機會、預測 2022年

Anti-Aging Therapies and Services Market -Trends and Growth Opportunities, Forecast to 2022

出版商 Frost & Sullivan 商品編碼 652582
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
抗老治療、服務市場:動向、成長機會、預測 2022年 Anti-Aging Therapies and Services Market -Trends and Growth Opportunities, Forecast to 2022
出版日期: 2018年06月05日內容資訊: 英文 112 Pages
簡介

本報告針對抗老治療、服務市場調查、提供抗老市場魅力與未來市場潛力、促進抗老技術需求因素、技術應用受矚目領域、影響市場的商業模式、技術供應商影響因素、與主要成長機會與投資建議。

第1章 摘要整理

第2章 市場概要

  • 世界人口急速高齡化
  • 隨著年紀疾病率大幅增加的成本壓力
  • 醫療模式不可能長期持續
  • 市場區分
  • 抗老動向
  • 地區考察

第3章 競爭策略

  • 市場機會
  • 破壞性的市場參與企業
  • 吸收、合併、與合作評價

第4章 促進因素、阻礙因素

  • 市場成長促進因素
  • 市場成長阻礙因素

第5章 預測、動向

  • 收益預測
  • 收益預測:區分分類
  • 收益預測議論

第6章 分類分析:營養補助食品

  • 主要調查結果
  • 市場工程測定
  • 預測前提條件、定義
  • 收益預測
  • 收益預測:2次區分分類
  • 收益預測討論
  • 收益預測:流通管道
  • 受矚目企業

第7章 分類分析:傳統治療法

  • 主要調查結果:傳統治療法
  • 主要調查結果:年齡產生的眼科疾病
  • 主要調查結果:神經病變
  • 主要調查結果:骨質疏鬆
  • 主要調查結果:關節變形
  • 主要調查結果:良性前列腺肥大
  • 市場工程測定
  • 預測前提條件、定義
  • 收益預測
  • 收益預測:2次區分分類
  • 收益預測議論
  • 受矚目企業

第8章 分類分析:美容整形、裝置與製品

  • 主要調查結果
  • 市場工程測定
  • 預測前提條件、定義
  • 收益預測
  • 收益預測:2次區分分類
  • 收益預測議論
  • 受矚目企業

第9章 市場未來

  • 抗老製品:規範政策必須進化
  • 未來主要動向:預防老化的多面方法

第10章 成長機會、行動喚起 (CTA)

  • 抗老治療、服務生態系統轉變
  • 抗老:5項主要成長機會
  • 成長機會1:再生醫療 - 幹細胞、基因療法
  • 成長機會2:加速老化因素的標的藥理學
  • 成長機會3:數位患者契合
  • 成長機會4: 臨床證實的補充品
  • 成長機會5:美容技術的效能
  • 成功、成長的策略需求、其他

第11章 結論

第12章 附錄

目錄
Product Code: MDB7-52

Focus on Integrative Solutions Combining Dietary Supplements and Aesthetic Solutions with Clinical Therapeutics as the Market Moves Toward a ‘Prevent-Manage-Repair’ Continuum

The rapidly aging global population is placing immense pressure on healthcare systems across countries and regions. The improvement in life expectancy levels has created a large cohort of aged patients who suffer from one or more chronic diseases. Traditionally, the approach towards the management of this issue has been on ‘repair’, i.e., treatment of the various age-related ailments such as Alzheimer's disease, Parkinson’s disease, osteoarthritis, osteoporosis, and age-related macular degeneration.

However, the industry is shifting focus and is widening its scope to a ‘prevent-manage-repair’ continuum, which is creating novel market opportunities for integrative approaches such innovative dietary supplements, aesthetics procedures, and alternative therapies (such as BHRT). Such approaches, along with advanced clinical therapeutics, such as regenerative medicine and pharmacological targeting of aging (focused on telomeres, rapalogs, senescent cell targeting, and mitochondria-based therapies) are key opportunities in this space.

Digital enablers are likely to gain prominence in the market, driving collaboration between drug and technology firms to cater to the ‘drug-as-a-service’ trend. Digital therapies that amalgamate mobile technology with AI and Big Data analytics for clinical effect will help lower costs and reduce drug side effects. Additionally, digital pills that can track medication consumption will improve drug adherence, a key challenge in the treatment of the elderly population. For example, the ABILIFY MYCITE from Proteus-a digital pill with an ingestible sensor, approved by the FDA for the delivery of Otsuka’s oral aripiprazole tablets-may boost adherence levels if used in the treatment of age-related disorders.

While offering multiple growth opportunities, the market is not without strategic challenges. Aging is an inherently complicated process with multiple complex pathways and mechanisms. Hence, clinical trials to identify novel age management therapies take a long time to show relevant results. The Targeting Aging with Metformin (TAME) clinical trial is a good example. Additionally, aging is still not recognized as a disease by regulatory bodies, making it difficult for companies to position their product launches. Many of the earlier Anti-Aging products launched in the market offered limited results, creating a consumer trust deficit for novel products.

From a regional perspective, the United States and Europe are key markets for age-related products and solutions, with a large patient base, high income levels, and wide exposure to aging management methodologies. However, regions such as APAC, with a growing elderly population and improvement in educational and income levels are expected to emerge as attractive markets.

Key Issues Addressed:

  • How attractive is the Anti-Aging market? What is the future market potential?
  • What are the factors driving the demand for age management solutions?
  • Who will be the key users in the future?
  • What will be the focal areas of technology application?
  • What are the business models that will affect the market?
  • What are the factors impacting solution providers?
  • What are the market dynamics around the key trends, as well as market drivers and restraints?
  • Which are the game-changing companies at work?
  • What are the strategic levers to stay on the growth trajectory?
  • What are the key growth opportunities and investment recommendations in this space?

Table of Contents

1. EXECUTIVE SUMMARY

  • Key Findings
  • Key Findings (continued)
  • Key Findings (continued)
  • Scope and Segmentation
  • Key Questions This Study Will Answer
  • Market Engineering Measurements-Dietary Supplements Segment
  • Market Engineering Measurements-Conventional Therapies Segment
  • Market Engineering Measurements-Aesthetic Procedures, Devices, and Products Segment
  • Big Market Themes
  • 3 Big Predictions

2. MARKET OVERVIEW

  • Rapidly Aging Global Population
  • Growing Incidence of Age-related Diseases Creating Significant Cost Pressure
  • Healthcare Models Not Sustainable in the Long Term
  • Market Segmentation
  • Anti-Aging Trends from 2017 to 2022
  • Regional Insights

3. COMPETITIVE PLAYBOOK

  • Market Opportunities
  • Market Opportunities (continued)
  • Disruptive Market Participants
  • Merger, Acquisition, and Partnership Assessment
  • Merger, Acquisition, and Partnership Assessment (continued)
  • Merger, Acquisition, and Partnership Assessment (continued)

4. DRIVERS AND RESTRAINTS

  • Market Drivers
  • Market Restraints

5. FORECASTS AND TRENDS

  • Revenue Forecast
  • Revenue Forecast by Segment
  • Revenue Forecast Discussion

6. SEGMENT ANALYSIS-DIETARY SUPPLEMENTS

  • Key Findings
  • Market Engineering Measurements
  • Forecast Assumptions and Definitions
  • Revenue Forecast
  • Revenue Forecast by Sub-segment
  • Revenue Forecast Discussion
  • Revenue Forecast Discussion (continued)
  • Revenue Forecast-Distribution Channels
  • Key Companies to Watch

7. SEGMENT ANALYSIS-CONVENTIONAL THERAPIES

  • Key Findings for Conventional Therapies
  • Key Findings for Age-related Ocular Diseases
  • Key Findings for Neuro-degenerative Diseases
  • Key Findings for Osteoporosis
  • Key Findings for Osteoarthritis
  • Key Findings for Benign Prostatic Hyperplasia
  • Market Engineering Measurements
  • Forecast Assumptions and Definitions
  • Revenue Forecast
  • Revenue Forecast by Sub-segment
  • Revenue Forecast Discussion
  • Key Companies to Watch

8. SEGMENT ANALYSIS-AESTHETIC PROCEDURES, DEVICES, AND PRODUCTS

  • Key Findings
  • Market Engineering Measurements
  • Forecast Assumptions and Definitions
  • Revenue Forecast
  • Revenue Forecast by Sub-segment
  • Revenue Forecast Discussion
  • Key Companies to Watch

9. FUTURE OF THE MARKET

  • Anti-Aging Products-Evolution of Regulatory Policy Needed
  • Key Future Trends-A Multi-pronged Approach to Manage Aging

10. GROWTH OPPORTUNITIES AND COMPANIES TO ACTION

  • Transformation in the Anti-Aging Therapies and Services Ecosystem
  • Anti-Aging-5 Major Growth Opportunities
  • Growth Opportunity Impact Analysis
  • Growth Opportunity 1-Regenerative Medicine: Stem Cell and Gene Therapy
  • Age-related Applications of Cell Therapy-Companies Analysis
  • Age-related Applications of Gene Therapy, Small Molecules/Biologics, and Tissue Engineering Applications-Company Analysis
  • Growth Opportunity 2-Pharmacological Targeting of the Drivers of Aging
  • Novel Clinical Therapies for Aging Prevention and Management
  • Prominent Alternative Therapies
  • Growth Opportunity 3-Digital Patient Engagement
  • Digital Therapeutics to Manage Age-related Conditions
  • Better Drug Adherence Using Digitally Enabled Pills
  • Growth Opportunity 4-Clinically Validated Supplements
  • Anti-Aging-focused Dietary Supplement Vendors
  • Novel Technology-Fasting-mimicking Diets
  • Prominent Anti-Aging Dietary Supplements
  • Growth Opportunity 5-Comfort and Efficacy of Aesthetic Solutions
  • Novel Technology-Micronization Nanotechnology for Topical Hyaluronic Acid Application and Stem Cells for Skin Rejuvenation
  • Strategic Imperatives for Success and Growth

11. THE LAST WORD

  • The Last Word-3 Big Predictions
  • Legal Disclaimer
  • A4M

12. APPENDIX

  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • Conventional Treatment-Competitive Landscape and Pipeline Analysis
  • Conventional Treatment-Competitive Landscape and Pipeline Analysis (continued)
  • Conventional Treatment-Competitive Landscape and Pipeline Analysis (continued)
  • Conventional Treatment-Competitive Landscape and Pipeline Analysis (continued)
  • Conventional Treatment-Competitive Landscape and Pipeline Analysis (continued)
  • Dietary Supplements-Competitive Landscape
  • Aesthetic Procedures, Devices, and Products-Competitive Landscape
  • Aesthetic Procedures, Devices, and Products-Competitive Landscape (continued)
  • Additional Sources of Information
  • Market Engineering Methodology